DUBLIN--(BUSINESS WIRE)--The "Global Haemostats Market (Flowables, Thrombin & Fibrin Sealants): Industry Analysis & Outlook (2019-2023)" report has been added to ResearchAndMarkets.com's offering.
Global Haemostats Market: Industry Analysis & Outlook (2019-2023) provides an extensive research and detailed analysis of the present market along with future outlook.
The key industry growth drivers for haemostats market are the growing ageing population, increasing cardiovascular surgical procedures, evolving personal healthcare expenditure and accelerating economic growth. The market is trending with rising pharmaceuticals research and development (R&D) expenditures and escalating e-commerce pharmaceutical products sales. However, there are some growth hindering factors in the market include stringent regulations and intense competition.
Regionally, the U.S. is expected to hold the leading position in the market, due to surging demand for thrombin and fibrin sealants by the physicians for adhering the patients damaged tissues & sealing the injured blood vessel(s) during operation.
Key players i.e. Johnson & Johnson (Ethicon Inc.), Pfizer Inc., Baxter International Inc. and Becton, Dickinson and Company are being profiled along with their respective financials and growth strategies.
Key Topics Covered:
1. Market Overview
1.1 Introduction
1.2 Classification
1.3 Product Mechanism
2. Global Haemostats Market
2.1 Global Haemostats Market Value Forecast
2.2 Global Haemostats Market Value by Products
2.2.1 Global Flowables Haemostats Market Value Forecast
2.2.2 Global Thrombin Haemostats Market Value Forecast
2.2.3 Global Fibrin Sealants Haemostats Market Value Forecast
2.3 Global Haemostats Market Value by Surgery Type
2.4 Global Haemostats Market Value by Region
3. Regional Haemostats Market
3.1 The U.S. Haemostats Market Value Forecast
3.2 The U.S. Haemostats Market Value by Products
3.2.1 The U.S. Flowables Haemostats Market Value Forecast
3.2.2 The U.S. Thrombin Haemostats Market Value Forecast
3.2.3 The U.S. Fibrin Sealants Haemostats Market Value Forecast
3.3 Europe Haemostats Market Value Forecast
3.4 Europe Haemostats Market Value by Products
3.4.1 Europe Fibrin Sealants Haemostats Market Value Forecast
3.4.2 Europe Flowables Haemostats Market Value Forecast
3.5 Europe Haemostats Market Value by Country
3.5.1 Germany Haemostats Market Value Forecast
3.5.2 Italy Haemostats Market Value Forecast
3.5.3 Spain Haemostats Market Value Forecast
4. Market Dynamics
4.1 Growth Drivers
4.1.1 Growing Ageing Population
4.1.2 Increasing Cardiovascular Surgical Procedures
4.1.3 Evolving Personal HealthCare Expenditure
4.1.4 Accelerating Economic Growth
4.2 Key Trends and Developments
4.2.1 Rising Pharmaceuticals Research and Development (R&D) Expenditures
4.2.2 Escalating E-Commerce Pharmaceutical Products Sales
4.3 Challenges
4.3.1 Stringent Regulations
4.3.2 Intense Competition
5. Competitive Landscape
5.1 Global Haemostats Market
5.1.1 Key Players - Revenue Comparison
5.1.2 Key Players - Market Cap Comparison
5.1.3 Key Players - Product Feature Comparison
5.1.4 Key Players - Product Price Comparison
5.2 US Haemostats Market
5.2.1 Key Players - Market Share Comparison
5.2.2 Key Players - Product Market Share Comparison
5.3 Europe Haemostats Market
5.3.1 Key Players - Product Market Share Comparison
5.4 Germany Haemostats Market
5.4.1 Key Players - Product Market Share Comparison
5.5 France Haemostats Market
5.5.1 Key Players - Product Market Share Comparison
6. Company Profiles
- Baxter International Inc.
- Becton, Dickinson and Company
- Johnson & Johnson (Ethicon Inc.)
- Pfizer Inc.
For more information about this report visit https://www.researchandmarkets.com/r/pbutgo
